Cell therapy could deliver huge blow against cancer

New York Times | 
Dr. [Steven] Rosenberg, Dr. Carl H. June...and Dr. Michel Sadelain...have been at the forefront of this research for decades,...[bringing] to ...
Cancer Patient

Trial involving genetically engineered cancer-killing cells halted over patient deaths

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Three patients in a ...
genomephotograph

Scientists discuss synthetic human genome: What would it mean for science and society?

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Scientists are now contemplating ...
GMO master

In 2015 worldwide acreage of GMO crops declined for first time since crops first commercialized

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. The world’s farmers have ...
zika virus aedes mosquito

Genetically engineered mosquitoes get tentative go-ahead to fight Zika

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. The federal government has moved ...

Genetic testing company releasing consumers’ data to public domain

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. In an unusual move, ...
zika virus aedes mosquito

Biotech billionaire on mission to put self-destructing mosquitoes to use against Zika

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. In the expanding realm ...

Blurred line between hemophilia patients, drug sellers raises ethical questions

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. LaQuenta Caldwell-Moody considered it ...

Gene therapy for blindness may become first ever approved in US

New York Times | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.  What could become the ...
Screen Shot at AM x

Monsanto may look to Bayer CropScience after abandoning Syngenta takeover

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Monsanto has abandoned its $47 ...
Featured Story Banner Science Community Agrees D c x

Administration proposal to overhaul GMO regulations welcomed, but sharp divide on goals

New York Times | 
The Obama administration said on July 2 that it would update the way the government regulated genetically modified crops and some ...

Is FDA-backed ‘Viagra’ for women a step towards gender equality in medicine?

New York Times | 
After an intense lobbying campaign, a federal advisory panel recommended approval of what would become the first drug to treat ...

Scientist who discovered CRISPR/Cas9 weighs future of new technology

New York Times | 
Three years ago, Jennifer A. Doudna, a biochemist at the University of California, Berkeley, helped make one of the most monumental ...

Why GMO-giant Monsanto made offer for Syngenta’s chemical-focused company

New York Times | 
Over the last two decades Monsanto has cast off its century-long history as a chemical company and refashioned itself as ...

New genetic test will make breast cancer screening affordable for more women

New York Times | 
A Silicon Valley start-up with some big-name backers is threatening to upend genetic screening for breast and ovarian cancer by ...

Law and Order: Using DNA to generate suspects’ facial profiles

New York Times | 
Police in Columbia, S.C., last month released a sketch of a possible suspect in a murder investigation. In what may ...

Myriad Genetics ends feud over breast cancer screening patent

New York Times | 
Myriad Genetics has essentially given up trying to stop other companies from offering tests for increased risk of breast cancer, ...
biosafety hazmat ebola

As cases decline, experts stress urgency of Ebola vaccine clinical trials in West Africa

New York Times | 
As authorities and drug companies hurriedly prepare to begin testing Ebola vaccines in West Africa, they are starting to contemplate ...

Will gene editing and other new GM techniques sidestep controversy over ‘foreign’ genes?

New York Times | 
Scotts Miracle-Gro Company is developing genetically modified grass that would need less mowing, be a deeper green and be resistant to ...

New method for clearing donated blood of viruses gains FDA approval

New York Times | 
The Food and Drug Administration on Tuesday approved the first system that could be used by blood banks to destroy ...
food and farm superweeds

New weed fighting herbicide-tolerant GMO trait approved

New York Times | 
The Agriculture Department has approved the commercial planting of corn and soybeans genetically engineered to survive being sprayed by the ...

Fertility clinics adopting high-tech strategies to pick best embryo for implantation

New York Times | 
Annika Levitt initially resisted the fertility clinic’s suggestion that only one embryo — rather than the usual two or more ...

Drugs that block genetic breaks on immune system lengthen cancer survival

New York Times | 
Drugs that unleash the body’s immune system to combat tumors could allow patients with advanced melanoma to live far longer ...

DNA test for cervical cancer gets FDA approval

New York Times | 
The Food and Drug Administration on Thursday approved the first alternative to the long-used Pap test as a primary screening ...
de b e c o

Genetic entrepreneur J. Craig Venter to tackle the problem of human aging

New York Times | 
Craig Venter sequenced the first human genome. He made the first synthetic cell. And now, for his next trick, he's ...

Powerful new DNA-editing method

New York Times | 
In the late 1980s, scientists at Osaka University in Japan noticed unusual repeated DNA sequences next to a gene they ...

Using genetic techniques to target just one species of insect

New York Times | 
Scientists and biotechnology companies are developing what could become the next powerful weapon in the war on pests — one ...

Huge new genomics study searches for roots of genetic disease in 100k people

New York Times | 
Here comes genomics, Take 2. Pharmaceutical companies invested heavily in genetic studies in the frenzy after the sequencing of the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists